Takafumi Horii – SVP, Head of Japan Oncology Business Unit,…
Experienced global leader Takafumi Horii explains the rationale behind returning to his home nation of Japan to head up Takeda’s Japan Oncology…
Ken-ichiro Hata – Representative Director &…
Dr Ken-ichiro Hata, representative director and chairperson of Japan's Forum for Innovative Regenerative Medicine (FIRM) outlines the organisation's…
Ryu Ogawa – CEO & Satoshi Tamaki – CSO, Molcure,…
Ryu Ogawa and Satoshi Tamaki of Japanese AI-powered drug discovery firm Molcure outline how their technology can supercharge the speed and efficiency…
Yoji Yuki – CEO, UniBio Corporation
Yoji Yuki, CEO of Japanese regenerative medicine company UniBio, recalls the roots behind the venture and its plant-based technology. He also sets out…
Interview: Osamu Nagayama – President, Japan BioIndustry…
Osamu Nagayama, president of the Japan BioIndustry Association (JBA) and chairman and CEO of Chugai Pharmaceutical, discusses Japan’s footprint in…
Yuzo Toda – Chairman, Forum for Innovative Regenerative…
Yuzo Toda, chairman of the Forum for Innovative Regenerative Medicine (FIRM) in Japan, discusses how the organization acts as a translational bridge…
Tatsuya Kondo – Chief Executive, Pharmaceuticals and…
Dr. Tatsuya Kondo is chief executive of Japan’s regulatory authority, the Pharmaceuticals and Medical Devices Agency (PMDA). Since taking the role…
Makoto Suematsu – President, Japan Agency for Medical…
Makoto Suematsu, president of the Japan Agency for Medical Research and Development (AMED), discusses AMED’s successful unification of Japan’s…
Interview: Eric Delarge – General Manager &…
Eric Delarge, general manager and representative director of Servier Japan, recently became the first member of the international pharma industry to…